Frank Rimerman Advisors’s GSK GSK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$670K Sell
13,916
-654
-4% -$33.4K 0.04% 342
2026
Q2
$764K Sell
14,570
-702
-5% -$37.1K 0.04% 312
2026
Q1
$843K Sell
15,272
-138
-0.9% -$7.48K 0.06% 272
2025
Q4
$756K Buy
15,410
+1,866
+14% +$87K 0.05% 293
2025
Q3
$585K Buy
13,544
+6,083
+82% +$238K 0.04% 333
2025
Q2
$287K Buy
+7,461
New +$285K 0.02% 467
2024
Q3
– Sell
-21,359
Closed -$822K – 541
2024
Q2
$822K Buy
+21,359
New +$898K 0.06% 248

Other funds holding GSK

Frank Rimerman Advisors's GSK Position: Q3 2026 in Review

Frank Rimerman Advisors reduced its GSK (GSK) stake by 4.5% in Q3 2026, selling an estimated $33.4K and leaving 13,916 shares worth $670K. The position accounts for 0.04% of the portfolio, ranked #342.

Frank Rimerman Advisors first reported a position in GSK in Q2 2024 and has held it in 7 quarters since. The position peaked at $843K in Q1 2026. 981 funds tracked by Wall St. Rank hold GSK as of Q3 2026.

  • Frank Rimerman Advisors held 13,916 shares of GSK worth $670K as of Q3 2026.
  • Frank Rimerman Advisors sold 654 GSK shares in Q3 2026, an estimated $33.4K.
  • GSK made up 0.04% of Frank Rimerman Advisors's portfolio in Q3 2026, its #342 holding.
  • Frank Rimerman Advisors first reported a position in GSK in Q2 2024 and has held it in 7 quarters since.
  • Frank Rimerman Advisors's GSK position peaked at $843K in Q1 2026.
  • 981 funds tracked by Wall St. Rank held GSK as of Q3 2026.

Based on Frank Rimerman Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.